Oximio Ukraine Recognised by Ministry of Health as a Critical Company to National Healthcare During Wartime

Oximio Ukraine is honoured to share that, as of January 2025, the Ministry of Health of Ukraine has officially recognized our role as critical to the national healthcare sector during wartime. This acknowledgment reflects Oximio Ukraine’s essential role in supporting and strengthening the country’s healthcare system in these challenging times.

To secure this recognition, we underwent a comprehensive evaluation process to demonstrate our vital contribution to Ukraine’s medical infrastructure.

This status enhances Oximio Ukraine’s business continuity capabilities during these challenging times. This recognition not only reinforces Oximio Ukraine’s local presence but also highlights the resilience of our entire global Group, as many global roles are based in Ukraine.

“We worked a lot to receive this status from the Ministry of Health,” said Olga Vizgalova, Managing Director of Oximio in Ukraine and Regional Director for Central Eastern Europe. “It is a reflection of the hard work and dedication of our entire team, whose commitment to excellence has enabled us to continue supporting Ukraine’s healthcare system and economy. This achievement strengthens our resolve to ensure the health and well-being of those who depend on us during these challenging times.”

We extend our heartfelt gratitude to all who contributed to this milestone. Their unwavering efforts make a meaningful impact within the company and in the broader healthcare landscape of Ukraine.

For further information on our clinical trial supply chain solutions in Ukraine, please view our website: https://oximio.com/network/ukraine/